Reach Out To...
Your Trusted Pharmaceutical Regulatory Partner
Bridging Your Path to Market Compliance
At MC Pharma, we value open communication and are keen on assisting you through your pharmaceutical regulatory journey in Africa. Contact us to discuss your needs and discover how our expertise can serve you.
Get in Touch
FAQ's
Quick Answers to Your Queries
Pharmaceutical regulatory companies in South Africa are required to comply with the regulations formed by the South African Health Products Regulatory Authority (SAHPRA). The Authority requires that a pharmaceutical manufacturer or wholesaler be licensed to manufacture, which may include a licence to import and/or export medicines, or to act as a wholesaler of medicines. Guidelines are issued by the Authority, from time to time, which relate to various matters including Good Manufacturing Practices (GMP) or Good Distribution Practices (GDP). All pharmaceutical manufacturers and wholesalers are required to comply with such guidelines.
The pharmaceutical regulatory environment in South Africa is complex and influenced by the country’s socio-economic paradigm. Some of the challenges faced by pharmaceutical regulatory companies in South Africa include poor regulatory environment, disparate regulatory requirements, uneven playing field, and inadequate financial resources.
Regulations impact pharmaceutical regulatory companies in South Africa by requiring them to comply with the regulations formed by the South African Health Products Regulatory Authority (SAHPRA). The Authority requires that a pharmaceutical manufacturer or wholesaler be licensed to manufacture, which may include a licence to import and/or export medicines, or to act as a wholesaler of medicines. Guidelines are issued by the Authority, from time to time, which relate to various matters including Good Manufacturing Practices (GMP) or Good Distribution Practices (GDP). All pharmaceutical manufacturers and wholesalers are required to comply with such guidelines.
Pharmaceutical regulatory companies in South Africa ensure drug safety by complying with the regulations formed by the South African Health Products Regulatory Authority (SAHPRA). The Authority requires that a pharmaceutical manufacturer or wholesaler be licensed to manufacture, which may include a licence to import and/or export medicines, or to act as a wholesaler of medicines. Guidelines are issued by the Authority, from time to time, which relate to various matters including Good Manufacturing Practices (GMP) or Good Distribution Practices (GDP). All pharmaceutical manufacturers and wholesalers are required to comply with such guidelines.
The trends and the market are changing constantly and an in depth and programmatic approach to analysing the data for each service and product requires an knowledgeable consultant to gather and compile.
International pharmaceutical regulatory companies operate in South Africa by complying with the regulations formed by the South African Health Products Regulatory Authority (SAHPRA). The Authority requires that a pharmaceutical manufacturer or wholesaler be licensed to manufacture, which may include a licence to import and/or export medicines, or to act as a wholesaler of medicines. Guidelines are issued by the Authority, from time to time, which relate to various matters including Good Manufacturing Practices (GMP) or Good Distribution Practices (GDP). All pharmaceutical manufacturers and wholesalers are required to comply with such guidelines.
Pharmaceutical regulatory companies in South Africa collaborate with drug manufacturers by ensuring that they comply with the regulations formed by the South African Health Products Regulatory Authority (SAHPRA). The Authority requires that a pharmaceutical manufacturer or wholesaler be licensed to manufacture, which may include a licence to import and/or export medicines, or to act as a wholesaler of medicines. Guidelines are issued by the Authority, from time to time, which relate to various matters including Good Manufacturing Practices (GMP) or Good Distribution Practices (GDP).